Cargando…
Research Status of Systemic Adjuvant Therapy for Early Breast Cancer
Breast cancer has surpassed lung cancer as the most common cause of cancer deaths, worldwide. Early breast cancers are treatment sensitive and patients under standardized treatment have prolonged. Breast cancer treatment has significantly evolved from the conventional surgical approach and radiother...
Autores principales: | Hu, Wenyu, Xu, Dongdong, Li, Nanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591494/ https://www.ncbi.nlm.nih.gov/pubmed/37864566 http://dx.doi.org/10.1177/10732748231209193 |
Ejemplares similares
-
Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis
por: Hu, Wenyu, et al.
Publicado: (2023) -
Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014) -
Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer
por: López-Tarruella, Sara, et al.
Publicado: (2009) -
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014) -
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)